These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23937566)

  • 21. The Fanconi anemia pathway and ICL repair: implications for cancer therapy.
    Wang LC; Gautier J
    Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):424-39. PubMed ID: 20807115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hsp90 and the Fanconi anemia pathway: a molecular link between protein quality control and the DNA damage response.
    Yamashita T; Oda T; Sekimoto T
    Cell Cycle; 2007 Sep; 6(18):2232-5. PubMed ID: 17881891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
    Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
    DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fancb deficiency impairs hematopoietic stem cell function.
    Du W; Amarachintha S; Erden O; Wilson A; Meetei AR; Andreassen PR; Namekawa SH; Pang Q
    Sci Rep; 2015 Dec; 5():18127. PubMed ID: 26658157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HES1 is a novel interactor of the Fanconi anemia core complex.
    Tremblay CS; Huang FF; Habi O; Huard CC; Godin C; Lévesque G; Carreau M
    Blood; 2008 Sep; 112(5):2062-70. PubMed ID: 18550849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair.
    Lima M; Bouzid H; Soares DG; Selle F; Morel C; Galmarini CM; Henriques JA; Larsen AK; Escargueil AE
    Oncotarget; 2016 May; 7(18):25885-901. PubMed ID: 27029031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agents.
    Jun DW; Hwang M; Kim HJ; Hwang SK; Kim S; Lee CH
    PLoS One; 2013; 8(10):e75905. PubMed ID: 24124520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.
    Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H
    Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.
    Kupfer GM; D'Andrea AD
    Blood; 1996 Aug; 88(3):1019-25. PubMed ID: 8704210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Holding All the Cards-How Fanconi Anemia Proteins Deal with Replication Stress and Preserve Genomic Stability.
    Datta A; Brosh RM
    Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30813363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Fanconi anemia pathway and DNA interstrand cross-link repair.
    Su X; Huang J
    Protein Cell; 2011 Sep; 2(9):704-11. PubMed ID: 21948210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer.
    Panneerselvam J; Park HK; Zhang J; Dudimah FD; Zhang P; Wang H; Fei P
    Cell Cycle; 2012 Aug; 11(15):2947-55. PubMed ID: 22828653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
    Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
    Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
    Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
    J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.
    Kim H; D'Andrea AD
    Genes Dev; 2012 Jul; 26(13):1393-408. PubMed ID: 22751496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
    Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
    Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FANCJ suppresses microsatellite instability and lymphomagenesis independent of the Fanconi anemia pathway.
    Matsuzaki K; Borel V; Adelman CA; Schindler D; Boulton SJ
    Genes Dev; 2015 Dec; 29(24):2532-46. PubMed ID: 26637282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members.
    Rathbun RK; Christianson TA; Faulkner GR; Jones G; Keeble W; O'Dwyer M; Bagby GC
    Blood; 2000 Dec; 96(13):4204-11. PubMed ID: 11110692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.